These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3922630)
41. Induction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice. Derrick SC; Yabe I; Morris S; Cowley S Clin Vaccine Immunol; 2016 Jul; 23(7):638-47. PubMed ID: 27226281 [TBL] [Abstract][Full Text] [Related]
42. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies. Rashid G; Gittel H; Ben-Efraim S Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454 [TBL] [Abstract][Full Text] [Related]
43. The effects of a tubercle bacillary lipid on lympho-reticular tissue and on the natural haemolysin to sheep red cells in the rabbit. O'Rourke GE; Pound AW Pathology; 1971 Apr; 3(2):107-13. PubMed ID: 4999374 [No Abstract] [Full Text] [Related]
44. Measurement and comparison of the proliferative and antibody response of neonatal, immature and adult murine spleen cells to T-dependent and T-independent antigens. Rabinowitz SG Cell Immunol; 1976 Feb; 21(2):201-16. PubMed ID: 4226 [No Abstract] [Full Text] [Related]
45. Alterations of murine immunologic responses after silica dust inhalation. Miller SD; Zarkower A J Immunol; 1974 Nov; 113(5):1533-43. PubMed ID: 4371507 [No Abstract] [Full Text] [Related]
46. Adjuvant effect of endotoxin; antibody response to sheep erythrocytes in mice after transfer of syngeneic lymphoid cells treated with bacterial lipopolysaccharide in vitro. Nakano M; Uchiyama T; Saito K J Immunol; 1973 Feb; 110(2):408-13. PubMed ID: 4567393 [No Abstract] [Full Text] [Related]
47. Biophysical and immunological characterization of the ESX-4 system ESAT-6 family proteins Rv3444c and Rv3445c from Mycobacterium tuberculosis H37Rv. Pandey H; Fatma F; Yabaji SM; Kumari M; Tripathi S; Srivastava K; Tripathi DK; Kant S; Srivastava KK; Arora A Tuberculosis (Edinb); 2018 Mar; 109():85-96. PubMed ID: 29559126 [TBL] [Abstract][Full Text] [Related]
48. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis. Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011 [TBL] [Abstract][Full Text] [Related]
49. In vivo activation of mouse spleen lymphocytes by lipid A in carrier-free form. Mita A; Ohta H; Mita T Immunology; 1982 Feb; 45(2):333-40. PubMed ID: 7037619 [TBL] [Abstract][Full Text] [Related]
50. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation. Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311 [TBL] [Abstract][Full Text] [Related]
51. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091 [TBL] [Abstract][Full Text] [Related]
52. T-h-2 immunity and CD3+CD45RBlow-activated T cells in mice immunized with recombinant bacillus Calmette-Guérin expressing HIV-1 principal neutralizing determinant epitope. Aravindhan V; Narayanan S; Gautham N; Prasad V; Kannan P; Jacobs WR; Narayanan P FEMS Immunol Med Microbiol; 2006 Jun; 47(1):45-55. PubMed ID: 16706787 [TBL] [Abstract][Full Text] [Related]
53. Reversal by the MER tubercle bacillus fraction of the suppressive effects of heterologous antilymphocytic serum (ALS) on the allograft reactivity of mice. Kuperman O; Feigis M; Weiss DW Cell Immunol; 1973 Sep; 8(3):484-9. PubMed ID: 4199204 [No Abstract] [Full Text] [Related]
54. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy. Lu M; Xia ZY; Bao L Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251 [TBL] [Abstract][Full Text] [Related]
55. Effect of an orally applied herbal immunomodulator on cytokine induction and antibody response in normal and immunosuppressed mice. Bodinet C; Lindequist U; Teuscher E; Freudenstein J Phytomedicine; 2002 Oct; 9(7):606-13. PubMed ID: 12487324 [TBL] [Abstract][Full Text] [Related]
56. The long-term antibody response of New Zealand Black mice to sheep red blood cells. Elkerbout EA; Hijmans W Immunology; 1974 May; 26(5):893-900. PubMed ID: 4605286 [TBL] [Abstract][Full Text] [Related]
57. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer. Moertel CG; Ritts RE; Schutt AJ; Hahn RG Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082 [TBL] [Abstract][Full Text] [Related]
58. Suppression of the primary immune response in vivo to sheep red blood cells by B-cell mitogens. Diamantstein T; Keppler W; Blitstein-Willinger E Immunology; 1976 Mar; 30(3):401-7. PubMed ID: 767254 [TBL] [Abstract][Full Text] [Related]
59. Induction of cutaneous plasma cell tumor as a complication of adjuvant immunotherapy with methanol extraction residue of bacillus Calmette-Guérin. Suster SM; Ronnen M; Huszar M; Pines A; Schibi-Brilliant G Oncology; 1987; 44(5):279-82. PubMed ID: 3670794 [TBL] [Abstract][Full Text] [Related]
60. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis]. Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]